Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
REGENERX BIOPHARMACEUTICALS INC (RGRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/09/2010 BW RegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac Damage
12/01/2010 BW RegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic Agents
11/30/2010 BW Researchers Identify Potential Thymosin Beta 4 Receptor
11/17/2010 BW RegeneRx Receives Australian Patent Using Tß4 for Treatment Of Gastrointestinal Disorders
11/16/2010 BW RegeneRx President and CEO to Present at Maxim Group Growth Conference
11/02/2010 BW RegeneRx Reports Positive Results of Preclinical Dry Eye Study
11/01/2010 BW RegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request Hearing
10/26/2010 BW RegeneRx Announces Letter to Stockholders Posted on Website
09/02/2010 BW RegeneRx Appoints R. Don Elsey to Board of Directors
07/19/2010 BW Researchers Report in Neuroscience that TB4 Improves Neurological Function after Stroke
07/08/2010 BW RegeneRx Awarded Australian Patent for New TB4 Applications
06/03/2010 BW Henry Ford Study: Synthetic Peptide May Regenerate Brain Tissue in Stroke Victims
06/02/2010 BW RegeneRx Announces Exercise of Over-Allotment Option for Recent Public Offering
05/18/2010 BW RegeneRx Announces Pricing of Public Offering
05/14/2010 BW First Human Data on RegeneRx's Drug Candidate RGN-259 Published in Archives of Ophthalmology
05/13/2010 BW RegeneRx Awarded $3 Million Grant from National Institutes of Health for Development of Heart Attack Drug
04/16/2010 BW RegeneRx Biopharmaceuticals Announces Proposed Public Offering
04/08/2010 BW New Tß4 Eye Data to be Presented at ARVO Meeting
03/05/2010 BW Researchers Report that Thymosin beta 4 Improves Neurological Function after Stroke
03/02/2010 BW RegeneRx Biopharmaceuticals' President and CEO to Present at 22nd Annual Roth Capital Growth Stock Conference
02/26/2010 BW Researchers Report Novel Biological Properties of Fragments of Thymosin Beta 4

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy